FlexNT NFC Tag [NTAG216]
The FlexNT is one of our next generation, high performance, RFID and NFC compliant transponders. The flexNT is coated in USP Class VI, ISO 10993 tested biopolymer which gives it an extremely thin profile and flexible structure suitable for installation just about anywhere.
The FlexNT can be read and written to by many types of ISO14443A based RFID systems, and all NFC compliant reader/writer devices including USB devices and NFC compatible mobile phones.
It can be read and written with devices using 13.56MHz RFID and all NFC compatible readers & writers, including USB devices and many NFC-enabled Android smartphones. They are rewritable and can store data such as your business card (vCard), medical and allergy information or emergency contact details.
WARNING This kit definitely contains dangerous things. The flexNT transponder has not been tested or certified by any regulatory agency for implantation or use inside the human body. Use of this device is strictly at your own risk.
- 13.56MHz ISO14443A & NFC Type 2 compliant NTAG216 RFID chipset
- 8x22x0.4mm flexible biopolymer package
- Fully NFC Type 2 compliant – compatible with all NFC devices
- ISO14443A – compatible with all ISO14443A RFID systems
Please be aware if you’re wanting a professional to do the install, there is no need to buy the Flex Implant. Simply purchase a KSEC Cyborg package of your choosing and select the Cyborg Centre for your installation then book in your professional installation.
– Do not install under any gripping surface (e.g. no palm side installations) – Do not install atop or parallel to any joints (flex device are only “semi-flexible”) – Incise skin with scalpel, making 9mm wide incision – Lift/separate dermal layer using elevator tool – Remove dermal tools from installation site – Slide flexNT under skin by hand, do not use gripping tools – Suture to close wound, do not pierce flexNT with suture needle
FlexNT vs xNT Performance
Things to know about the FlexNT
– The biopolymer is ISO 10993 and USP Class IV tested and certified, however the final product has not been tested post-processing, meaning material changes during processing could render the final product unsafe in some way. Testing is planned for later, however beta testers have had the flexNT since April 2016 and report no issues. Dangerous Things founder and CEO Amal Graafstra underwent the first installation of a flex line device (a flexNT beta) on 03/02/2016 above the second metacarpal of the ring finger of his left hand. So far the installation has healed excellently and there are no signs of rejection or irritation at the installation site.
– There is no “preferred” location for installation of a flexNT. Customers are free to install the flexNT into any area of the body their installation professional is comfortable with, as long as it is in the fascia layer between dermis and muscle tissue. Even though we use images which suggest installation above the second metacarpal of one of the fingers, it is not an ideal location for such a device. Fingers are filled with tendons, nerve bundles, and very important things all packed into a very tight space. We urge you to think about easier locations like the back of the hand or in the arm/wrist.
Check out Post here about the FlexNT NFC Tag usages